Literature DB >> 20472365

Overall survival benefit from postoperative radiation therapy for organ-confined, margin-positive prostate cancer.

Robert O Dillman1, Russell Hafer, Craig Cox, Stephanie E McClure.   

Abstract

PURPOSE: Radical prostatectomy for invasive prostate cancer is associated with positive margin rates in 10% to 50% of resected specimens. Postoperative radiation therapy may benefit patients who have organ-confined prostate cancer with positive margins. METHODS AND MATERIALS: We performed a retrospective analysis to examine whether adjunctive radiation therapy enhanced long-term survival for prostate cancer patients who underwent prostatectomy for localized prostate cancer but with positive margins. We used the Hoag Cancer Center database to identify patients diagnosed with invasive prostate cancer. Relative and overall survival rates were calculated.
RESULTS: Among 1,474 patients diagnosed with localized invasive prostate cancer during the years 1990 to 2006 and undergoing prostatectomy, 113 (7.7%) were identified who had positive margins and did not have local extension of disease, positive lymph nodes, or distant metastases. A total of 17 patients received adjunctive radiation therapy (Group A), whereas 96 did not (Group B; 3 received hormonal therapy). Both groups had a median age of 64 years and median follow-up of 7.5 years. In Group A, no patients have died as of last follow-up, but in Group B, 18 have died. Estimated 10-year and 15-year overall survival rates were both 100% for Group A compared with 85% and 57% respectively for Group B (p2=0.050, log rank). Relative 10- and 15 year survival rates were both 100% for Group A compared with 100% and 79% respectively for Group B.
CONCLUSIONS: This retrospective analysis suggests that prostate cancer patients with localized disease but positive margins do derive a survival benefit from adjuvant radiation therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20472365     DOI: 10.1016/j.ijrobp.2009.11.041

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

Review 1.  [Organ-limited prostate cancer with positive resection margins. Importance of adjuvant radiation therapy].

Authors:  D Porres; D Pfister; B Brehmer; A Heidenreich
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation.

Authors:  Hua-chun Luo; Li-ping Cheng; Hui-hua Cheng; Zhi-chao Fu; Shao-guang Liao; Dong-shi Li; Wen-fa Zheng; Gui-shan Lin; Jin-feng Zhu; Jian-feng Xu; Qin Yin; Qing-yang Yu
Journal:  Med Oncol       Date:  2014-05-22       Impact factor: 3.064

3.  Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery.

Authors:  Michael J Donovan; Faisal M Khan; Douglas Powell; Valentina Bayer-Zubek; Carlos Cordon-Cardo; Jose Costa; James Eastham; Peter Scardino
Journal:  BJU Int       Date:  2011-07-19       Impact factor: 5.588

4.  Prostate cancer treated with reduced-volume intensity-modulated radiation therapy: Report on the 5-year outcome of a prospective series.

Authors:  Hua-Chun Luo; Zhi-Chao Fu; Hui-Hua Cheng; Yong Lei; Shao-Guang Liao; Jing Feng; Qin Yin; Qun-Hua Chen; Gui-Shan Lin; Jin-Feng Zhu; Jian-Feng Xu; Wang Dian
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.